GlassScriptPhysician profile
Manpreet Kaur
NPI 1316588411
$1,775.75
in general payments reported to CMS, 2019-2025
20 companies · $625 in 2025
The $625 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.71 · 2022: $53.08 · 2023: $523 · 2024: $498 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.85 |
| Travel and Lodging | $288.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $599.96 | 2025 | Prevena, V.A.C. Veraflo |
| Scpharmaceuticals INC. | $347.56 | 2023-2024 | |
| Medtronic, INC. | $140.82 | 2021-2024 | Onyx Frontier, Azure Xt Dr Mri Surescan, Corevalve Evolut R |
| Terumo Medical Corporation | $139.15 | 2023 | Glidesheath Slender |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.34 | 2021-2024 | Lifevest |
| Abbott Laboratories | $64.97 | 2024 | Assurity |
| Kestra Medical Technology Services, INC. | $55.24 | 2024 | Assure Wcd |
| Atricure, INC. | $52.29 | 2021-2022 | |
| Abiomed | $46.14 | 2024 | Impella |
| Boston Scientific Corporation | $32.44 | 2023 | |
| Pfizer INC. | $25.10 | 2025 | |
| Chiesi USA, INC. | $24.80 | 2023 | Kengreal |
| Edwards Lifesciences Corporation | $22.53 | 2022 | |
| Csl Behring | $21.80 | 2023 | Kcentra |
| Cerus Corporation | $20.77 | 2023 | Intercept Blood System For Platelets |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.10 | 2023 | Tagrisso |
| Trevena, INC. | $14.03 | 2021 | |
| Biomerieux INC | $14.00 | 2024 | Vidas Nephrocheck |
| Blue Surgical LLC | $13.66 | 2024 | |
| Ambu INC. | $13.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.